Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Multicenter Study
. 2019 Aug;66(8):A5559.

Short-term outcomes after minimally invasive oesophagectomy

Affiliations
  • PMID: 31315797
Free article
Multicenter Study

Short-term outcomes after minimally invasive oesophagectomy

Alan Patrick Ainsworth et al. Dan Med J. 2019 Aug.
Free article

Abstract

Introduction: Minimally invasive oesophagectomy (MIO) has gained increasing popularity. This study reports the results of the first patients operated using this technique at our department.

Methods: All procedures were prospectively registered in a database. Patients were followed until death, two years after surgery or 1 January 2019.

Results: A total of 150 procedures were performed (from 23 November 2015 to 27 February 2018). The median proced-ure time decreased from 350 minutes for the initial 75 pa-tients to 320 minutes for the final 75 patients (p < 0.05). Blood loss decreased from 200 ml to 100 ml (p < 0.05), respectively. The conversion rate for the abdominal procedure was 7% for the initial 75 patients and 8% for the final 75 patients (not significant (NS)). For the thoracic procedure, the corresponding figures were 11% and 7% (NS), respectively. Anastomotic leakage was seen in 17% (initial patients) and 11% (final patients) (NS); however, less than 20% of the leakages needed surgical treatment. The median length of post-operative stay was nine days for both groups. For all 150 patients, pulmonary complications were observed in 18% and cardiac complications in 11%. The 30-day mortality rate was 2% and the one-year survival rate was 86% (124 registered patients).

Conclusions: MIO was introduced at our department with acceptable morbidity and mortality rates and the short-term oncological result was not compromised.

Funding: none.

Trial registration: The study was approved as a quality project by the Region of Southern Denmark (18/37355).

PubMed Disclaimer

Publication types

MeSH terms

LinkOut - more resources